MRNA
Moderna Inc
NASDAQ: MRNA · HEALTHCARE · BIOTECHNOLOGY
$45.72
-3.01% today
Updated 2026-04-29
Market cap
$18.13B
P/E ratio
—
P/S ratio
9.33x
EPS (TTM)
$-7.26
Dividend yield
—
52W range
$22 – $60
Volume
7.5M
Moderna Inc (MRNA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.78M | $-738152.00 | $66.73M | $-331.48M | $-330.87M | $-458.97M | $2.03B | $13.62B | $4.98B | $-3.12B | $-3.00B | $-1.87B |
| Capital expenditures | $0.00 | $0.00 | $33.14M | $58.40M | $105.77M | $31.55M | $67.45M | $284.00M | $400.00M | $707.00M | $1.05B | $192.00M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $39.36M | $40.05M | $72.56M | $81.12M | $93.02M | $142.00M | $226.00M | $305.00M | $429.00M | $483.00M |
| Free cash flow | $-4.78M | $-738152.00 | $33.59M | $-389.88M | $-436.63M | $-490.52M | $1.96B | $13.34B | $4.58B | $-3.83B | $-4.05B | $-2.06B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $633000.00 | $1.48M | — | — | $7.04M | $124.00M | $184.00M | $270.00M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $523.50M | $-422.79M | $2.39B | $4.22B | $-3.64B | — | — | — |